Generic Oncology Drugs Market

1   Preface
2   Scope and Methodology
    2.1    Objectives of the study
    2.2    Stakeholders
    2.3    Data Sources
        2.3.1    Primary Sources
        2.3.2    Secondary Sources
    2.4    Market Estimation
        2.4.1    Bottom-Up Approach
        2.4.2    Top-Down Approach
    2.5    Forecasting Methodology
3   Executive Summary
4   Introduction
    4.1    Overview
    4.2    Key Industry Trends
5   Global Generic Drug Market
    5.1    Market Overview
    5.2    Market Performance
    5.3    Market Breakup by Region
    5.4    Market Forecast
6   Global Generic Oncology Drug Market
    6.1    Market Overview
    6.2    Market Trends
    6.3    Impact of COVID-19
    6.4    Top Generic Oncology Drugs
    6.5    Price Analysis
    6.6    Market Forecast
    6.7    SWOT Analysis
        6.7.1 Overview
        6.7.2 Strengths
        6.7.3 Weaknesses
        6.7.4 Opportunities
        6.7.5 Threats
    6.8    Value Chain Analysis
        6.8.1 Research and Development
        6.8.2 Manufacturing
        6.8.3 Marketing
        6.8.4 Distribution
    6.9   Porter’s Five Forces Analysis
        6.9.1 Overview
        6.9.2 Bargaining Power of Buyers
        6.9.3 Bargaining Power of Suppliers
        6.9.4 Degree of Competition
        6.9.5 Threat of New Entrants
        6.9.6 Threat of Substitutes
        6.9.7 Regulations in the Generics Industry
    6.10    Key Market Drivers and Success Factors
7   Global Generic Oncology Drug Market: Performance of Key Regions
    7.1    North America
    7.2    Europe
    7.3    Asia Pacific
    7.4    Middle East and Africa
    7.5    Latin America
8   Global Generic Oncology Drug Market: Competitive Landscape
    8.1    Market Structure
    8.2    Market Breakup by Key Players
    8.3    Key Player Profiles
 9  Generic Oncology Drug Manufacturing Process
    9.1    Product Overview
    9.2    Detailed Process Flow (Tablets)
    9.3    Detailed Process Flow (Injectable)
    9.4    Various Types of Unit Operations Involved
    9.5    Mass Balance and Raw Material Requirements
10  Project Details, Requirements and Costs Involved
    10.1    Land Requirements and Expenditures
    10.2    Construction Requirements and Expenditures
    10.3    Plant Machinery
    10.4    Machinery Pictures
    10.5    Raw Material Requirements and Expenditures
    10.6    Packaging Requirements and Expenditures
    10.7    Transportation Requirements and Expenditures
    10.8    Utility Requirements and Expenditures
    10.9    Manpower Requirements and Expenditures
    10.10    Other Capital Investments
11  Loans and Financial Assistance
12  Project Economics
    12.1    Capital Cost of the Project
    12.2    Techno-Economic Parameters
    12.3    Product Pricing and Margins Across Various Levels of the Supply Chain
    12.4    Taxation and Depreciation
    12.5    Income Projections
    12.6    Expenditure Projections
    12.7    Financial Analysis
    12.8    Profit Analysis

List of Figures

Figure 1: Global: Generic Drug Market: Major Drivers and Challenges
Figure 2: Global: Generic Drug Market: Sales Value Trends (in Billion US$), 2018-2023
Figure 3: Global: Generic Drug Market Forecast: Sales Value Trends (in Billion US$), 2024-2032
Figure 4: Global: Generic Drug Market: Breakup by Region (in %), 2023
Figure 5: Global: Generic Oncology Drug Industry Overview
Figure 6: Global: Generic Oncology Drug Market: Sales Value Trends (in Billion US$), 2018-2023
Figure 7: Global: Generic Oncology Drug Market Forecast: Sales Value Trends (in Billion US$), 2024-2032
Figure 8: Global: Generic Oncology Drug Market: Breakup by Region (in %), 2023
Figure 9: Global: Generic Oncology Drug Industry: SWOT Analysis
Figure 10: Global: Generic Oncology Drug Industry: Value Chain Analysis
Figure 11: Global: Generic Oncology Drug Industry: Porter’s Five Forces Analysis
Figure 12: North America: Generic Oncology Drug Market (in Million US$), 2018, 2024 & 2032
Figure 13: Asia Pacific: Generic Oncology Drug Market (in Million US$), 2018, 2024 & 2032
Figure 14: Europe: Generic Oncology Drug Market (in Million US$), 2018, 2024 & 2032
Figure 15: Latin America: Generic Oncology Drug Market (in Million US$), 2018, 2024 & 2032
Figure 16: Middle East and Africa: Generic Oncology Drug Market (in Million US$), 2018, 2024 & 2032
Figure 17: Generic Oncology Drug Industry: Profit Margins at Various Levels of the Supply Chain
Figure 18: Generic Oncology Drug Manufacturing: Production Cost Breakup (in %)
Figure 19: Generic Oncology Drug Manufacturing Plant: Detailed Process Flow
Figure 20: Generic Oncology Drug Manufacturing Process: Conversion Rate of Feedstocks
Figure 21: Generic Oncology Drug Manufacturing Plant: Proposed Plant Layout
Figure 22: Generic Oncology Drug Manufacturing Plant: Breakup of Capital Costs (in %)

List of Tables

Table 1: Global: Generic Drug Market: Key Industry Highlights, 2023 and 2032
Table 2: Global: Generic Drug Market Forecast: Breakup by Region, 2024-2032
Table 3: Global: Generic Oncology Drug Market: Key Industry Highlights, 2023 and 2032
Table 4: Generic Oncology Drug Manufacturing Plant: Costs Related to Land and Site Development (in US$)
Table 5: Generic Oncology Drug Manufacturing Plant: Costs Related to Civil Works (in US$)
Table 6: Generic Oncology Drug Manufacturing Plant: Costs Related to Machinery Unit (in US$)
Table 7: Generic Oncology Drug Manufacturing Plant: Raw Material Requirements
Table 8: Generic Oncology Drug Manufacturing Plant: Costs Related to Salaries and Wages (in US$)
Table 9: Generic Oncology Drug Manufacturing Plant: Costs Related to Other Capital Investments (in US$)
Table 10: Details of Financial Assistance Offered by Financial Institutions
Table 11: Generic Oncology Drug Manufacturing Plant: Capital Costs (in US$)
Table 12: Generic Oncology Drug Manufacturing Plant: Techno-Economic Parameters
Table 13: Generic Oncology Drug Manufacturing Plant: Taxation and Depreciation
Table 14: Generic Oncology Drug Manufacturing Plant: Income Projections (in US$)
Table 15: Generic Oncology Drug Manufacturing Plant: Expenditure Projections (in US$)
Table 16: Generic Oncology Drug Manufacturing Plant: Cash Flow Analysis Without Considering the Income Tax Liability
Table 17: Generic Oncology Drug Manufacturing Plant: Cash Flow Analysis on Considering the Income Tax Liability
Table 18: Generic Oncology Drug Manufacturing Plant: Profit and Loss Account